Cardiovascular News & Research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Cardiovascular

Alirocumab and statin therapy leads to plaque regression in acute MI

Alirocumab and statin therapy leads to plaque regression in acute MI

Study suggests increased coffee consumption lowers rate of kidney function decline in diabetics

Study suggests increased coffee consumption lowers rate of kidney function decline in diabetics

Adding coronary artery calcium scores to CVD risk assessment provides no clinical benefit

Adding coronary artery calcium scores to CVD risk assessment provides no clinical benefit

Sponsored

TAVI Resource Hub

Using nitrate and PDE5 inhibitors together not associated with a higher incidence of adverse CV events

Using nitrate and PDE5 inhibitors together not associated with a higher incidence of adverse CV events

Fish diet best for reducing risk of developing type 2 diabetes

Fish diet best for reducing risk of developing type 2 diabetes

Early glycaemic control in type 2 diabetes reduces subsequent adverse CV outcomes

Early glycaemic control in type 2 diabetes reduces subsequent adverse CV outcomes

Meta-analysis finds sodium-glucose co-transporter-2 inhibitors reduce adverse CV outcomes in acute decompensated heart failure

Meta-analysis finds sodium-glucose co-transporter-2 inhibitors reduce adverse CV outcomes in acute decompensated heart failure

Systematic review finds that cardiac data from smartwatches are potentially less accurate for darker skinned individuals

Systematic review finds that cardiac data from smartwatches are potentially less accurate for darker skinned individuals

Reduced sodium intake does not lower clinical events in heart failure patients

Reduced sodium intake does not lower clinical events in heart failure patients

Should daily coffee intake be part of a healthy diet?

Should daily coffee intake be part of a healthy diet?

Greater CV risk reduction with lower dose pioglitazone in patients with insulin resistance

Greater CV risk reduction with lower dose pioglitazone in patients with insulin resistance

Real-world analysis reveals high level of recurrent cardiovascular events and death 6 months after primary episode

Real-world analysis reveals high level of recurrent cardiovascular events and death 6 months after primary episode